160 related articles for article (PubMed ID: 33962833)
21. Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer.
Simons JM; van Pelt MLMA; Marinelli AWKS; Straver ME; Zeillemaker AM; Pereira Arias-Bouda LM; van Nijnatten TJA; Koppert LB; Hunt KK; Smidt ML; Luiten EJT; van der Pol CC
Br J Surg; 2019 Nov; 106(12):1632-1639. PubMed ID: 31593294
[TBL] [Abstract][Full Text] [Related]
22. The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Aguayo-Albasini JL
Cir Esp (Engl Ed); 2020 Nov; 98(9):510-515. PubMed ID: 32386728
[TBL] [Abstract][Full Text] [Related]
23. Different strategies in marking axillary lymph nodes in breast cancer patients undergoing neoadjuvant medical treatment: a systematic review.
Man V; Kwong A
Breast Cancer Res Treat; 2021 Apr; 186(3):607-615. PubMed ID: 33611665
[TBL] [Abstract][Full Text] [Related]
24. Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype.
Di Micco R; Zuber V; Fiacco E; Carriero F; Gattuso MI; Nazzaro L; Panizza P; Gianolli L; Canevari C; Di Muzio N; Pasetti M; Sassi I; Zambetti M; Gentilini OD
Eur J Surg Oncol; 2019 Jun; 45(6):969-975. PubMed ID: 30744944
[TBL] [Abstract][Full Text] [Related]
25. Combining Wire Localization of Clipped Nodes with Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: Preliminary Results from a Prospective Study.
García-Novoa A; Acea-Nebril B; Díaz Carballada C; Bouzón Alejandro A; Conde C; Cereijo Garea C; Varela JR; Santiago Freijanes P; Antolín Novoa S; Calvo Martínez L; Díaz I; Rodríguez Martínez S; Mosquera Oses J
Ann Surg Oncol; 2021 Feb; 28(2):958-967. PubMed ID: 32725521
[TBL] [Abstract][Full Text] [Related]
26. Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients.
Simons JM; Scoggins ME; Kuerer HM; Krishnamurthy S; Yang WT; Sahin AA; Shen Y; Lin H; Bedrosian I; Mittendorf EA; Thompson A; Lane DL; Hunt KK; Caudle AS
Ann Surg Oncol; 2021 Aug; 28(8):4277-4283. PubMed ID: 33417121
[TBL] [Abstract][Full Text] [Related]
27. When the clipped node goes missing, CT guided SAVI SCOUT placement: A novel approach for localizing soft tissue targets.
Lifrieri A; Fuzesi S; Desperito E; Taback B
Clin Imaging; 2022 May; 85():115-117. PubMed ID: 35278870
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
Park S; Lee JE; Paik HJ; Ryu JM; Bae SY; Lee SK; Kim SW; Nam SJ
Clin Breast Cancer; 2017 Feb; 17(1):e19-e29. PubMed ID: 27495997
[TBL] [Abstract][Full Text] [Related]
29. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
30. The 'twinkle' artifact - A novel method of clip identification to facilitate targeted axillary surgery following neoadjuvant chemotherapy in breast cancer patients.
Tan MP; Bi Z; Ong EMW
Clin Imaging; 2020 Dec; 68():36-44. PubMed ID: 32563723
[TBL] [Abstract][Full Text] [Related]
31. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure.
Derkx F; Maaskant-Braat AJ; van der Sangen MJ; Nieuwenhuijzen GA; van de Poll-Franse LV; Roumen RM; Voogd AC
Eur J Surg Oncol; 2010 Jul; 36(7):646-51. PubMed ID: 20537838
[TBL] [Abstract][Full Text] [Related]
32. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.
Donker M; Straver ME; Wesseling J; Loo CE; Schot M; Drukker CA; van Tinteren H; Sonke GS; Rutgers EJ; Vrancken Peeters MJ
Ann Surg; 2015 Feb; 261(2):378-82. PubMed ID: 24743607
[TBL] [Abstract][Full Text] [Related]
33. Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer.
Mariscal Martínez A; Vives Roselló I; Salazar Gómez A; Catanese A; Pérez Molina M; Solà Suarez M; Pascual Miguel I; Blay Aulina L; Ríos Gozálvez C; Julián Ibáñez JF; Rodríguez Martínez P; Martínez Román S; Margelí Vila M; Luna Tomás MA
Surg Oncol; 2021 Mar; 36():28-33. PubMed ID: 33285433
[TBL] [Abstract][Full Text] [Related]
34. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review.
Lee MC; Plews R; Rawal B; Kiluk JV; Loftus L; Laronga C
Ann Surg Oncol; 2012 Jun; 19(6):1818-24. PubMed ID: 22203185
[TBL] [Abstract][Full Text] [Related]
35. Radio-isotope occult lesion localization (ROLL) techniques to identify the clipped node for targeted axillary dissection (TAD) in breast cancer.
Winder AA; Spillane AJ; Sood S; McKessar M; Cohn D; Snook K
ANZ J Surg; 2022 Nov; 92(11):3017-3021. PubMed ID: 36262092
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization.
Sun J; Henry DA; Carr MJ; Yazdankhahkenary A; Laronga C; Lee MC; Hoover SJ; Sun W; Czerniecki BJ; Khakpour N; Kiluk JV
Clin Breast Cancer; 2021 Jun; 21(3):e189-e193. PubMed ID: 32893094
[TBL] [Abstract][Full Text] [Related]
37. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
38. Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.
van der Noordaa MEM; van Duijnhoven FH; Straver ME; Groen EJ; Stokkel M; Loo CE; Elkhuizen PHM; Russell NS; Vrancken Peeters MTFD
Ann Surg Oncol; 2018 Jun; 25(6):1512-1520. PubMed ID: 29511992
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
[TBL] [Abstract][Full Text] [Related]
40. Excision of axillary lymph node recurrences in breast cancer patients with axillary ROLL (A-ROLL).
Aydogan F; Ozben V; Atasoy D; Yilmaz MH; Halaç M; Celik V
J Surg Oncol; 2010 Feb; 101(2):141-4. PubMed ID: 19937993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
